Ravel Health
Early Stage
Virtual consultations for Lyme patients.
Overview
Raised: $73,650
Total Commitments ($USD)
Platform
Wefunder
Start Date
05/18/2023
Close Date
05/23/2023
Min. Goal
$50,000
Max. Goal
$124,000
Min. Investment
$100
Security Type
SAFE
Series
Seed
SEC Filing Type
RegCF
Valuation Cap
$5,000,000
Discount
20%
Rolling Commitments ($USD)
Status
Funded
Reporting Date
05/31/2023
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$14,730
# of Investors
34
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2021
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2C
Margin
High
Capital Intensity
Low
Ravel Health, with a valuation of $5 million, is raising funds on Wefunder. The company is a virtual, integrative nationwide clinic specializing in chronic Lyme disease & its many co-infectionshas developed a platform that provides AI and ML-powered subscription-based career strategies. Ravel Health's goal is to provide affordable, on-demand from highly vetted Lyme-literate professionals, all from the comford of home. Kevin Williams and Jaime Intile founded Ravel Health in November 2021. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $124,000. The campaign proceeds will be used for development, legal fees, a Chief Medical Officer & provider training pipeline and, toward marketing/PR.
Summary Profit and Loss Statement
| FY 2022 | FY 2021 | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-7,679 |
$-86 |
Summary Balance Sheet
| FY 2022 | FY 2021 | |
|---|---|---|
|
Cash |
$2,130 |
$2,500 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$2,130 |
$2,500 |
|
Short-Term Debt |
$0 |
$1,086 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$0 |
$1,086 |
Financials as of: 05/18/2023
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Ratings 
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.